The prevalence of thyroid dysfunction in an iodine-sufficient area in Iran

Archives of Iranian Medicine

Volumn 12, Issue 3, 2009, Pages 262-270

  Aminorroaya, Ashraf ^a   Janghorbani, Mohsen ^b   Amini, Masoud ^a   Hovsepian, Silva ^a   Tabatabaei, Azamosadat ^a   Fallah, Zahra ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adult; Autoimmunity; Hypothyroidism; Iodine; Iran

Indexed keywords

IODINE; LIOTHYRONINE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CLUSTER ANALYSIS; EUTHYROIDISM; FEMALE; HEALTH SURVEY; HOUSEHOLD; HUMAN; HYPOTHYROIDISM; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; THYROID DISEASE; THYROXINE BLOOD LEVEL; AGE DISTRIBUTION; BLOOD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPOTHYROIDISM; IODINE; IRAN; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; THYROTROPIN; YOUNG ADULT;

EID: 69149099483     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Roberts CG, Ladenson PW. Hypothyroidism. Lancet. 2004; 363: 793-803.
2. Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular, and all-cause mortality: a meta-analysis. Int J Cardiol. 2008; 125: 41-48.
3. Haggerty JJ Jr., Stern RA, Mason GA, Beckwith J, Morey CE, Prange AJ Jr. Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry. 1993; 150: 508-510.
4. Copper DS. Subclinical hypothyroidism. New Engl J Med. 2001; 345: 260-265.
5. Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA. 1996; 276: 285-292.
6. Vaderpump MPJ, Tunbridge WMG. The epidemiology of thyroid diseases. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the Thyroid. Philadelphia: Lippincott-Raven; 2000: 467-473.
7. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977; 7: 481-493.
8. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000; 160: 526-534.
9. Eggertsen R, Petersen K, Lundberg PA, Nystrom E, Lindstedt G. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. BMJ. 1988; 297: 1586-1592.
10. Konno N, Yuri K, Taguchi H, Miura K, Taguchi S, Hagiwara K, et al. Screening for thyroid diseases in an iodine- sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin Endocrinol (Oxf). 1993; 38: 273-281.
11. Völzke H, Lüdemann J, Robinson DM, Spieker KW, Schwahn C, Kramer A, et al. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid. 2003; 13: 803-810.
12. Delange F. The disorders induced by iodine deficiency. Thyroid. 1994; 4: 107-128.
13. Sichieri R, Baima J, Marante T, de Vasconcellos MT, Moura AS, Vaisman M. Low prevalence of hypothyroidism among black and Mulatto people in a population-based study of Brazilian women. Clin Endocrinol (Oxf). 2007; 66: 803-807.
14. Azizi F, Mehran L, Sheikholeslam R, Ordookhani A, Naghavi M, Hedayati M, et al. Sustainability of a well-monitored salt iodization program in Iran: marked reduction in goiter prevalence and eventual normalization of urinary iodine concentrations without alteration in iodine content of salt. J Endocrinol Invest. 2008; 31: 422-431
15. Aminorroaya A, Amini M, Rezvanian H, Kachoie A, Sadri G, Mirdamadi M, et al. Effects of iodized salt consumption on goiter prevalence in Isfahan: the possible role of goitrogens. Endocr Pract. 2001; 7: 95-98.
16. Azizi F, Delshad H, Amouzegar A. Marked reduction in goiter prevalence and eventual normalization of urinary iodine concentrations in Iranian schoolchildren, 10 years after universal salt iodination (Third National Survey of Iodine Deficiency Disorders 2000). Iran J Endocrinol Metabol. 2008; 10: 191-203.
17. Padberg S, Heller K, Usadel KH, Schumm-Draeger PM. One-year prophylactic treatment of euthyroid Hashimoto's thyroiditis patients with levothyroxine: is there a benefit? Thyroid. 2001; 11: 249-255.
18. Hoffman RG, Broughton PMG.New Clinical, Laboratory Standardization Methods. New York: Exposition Press; 1974.
19. Stockigt JR. Serum thyrotropin and thyroid hormone measurement and assessment of thyroid hormone transport. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the Thyroid. Philadelphia: Lippincott-Raven; 2000: 378.
20. International Council for Control of Iodine Deficiency Disorders, UNICEF, World Health Organization. Assessment of Iodine Deficiency Disorders and Monitoring their Elimination: A Guide for Programme Managers. 2nd ed. Geneva: World Health Organization; c2001.
21. International Council for Control of Iodine Deficiency Disorders, UNICEF, World Health Organization. Indicators for Assessing Iodine Deficiency Disorders and their Control through Salt Iodization. Geneva: World Health Organization, 1994.
22. Sawin CT, Chopra D, Azizi F, Mannix JE, Bacharach P. The aging thyroid: increased prevalence of serum thyrotropin levels in the elderly. JAMA. 1979; 242: 247-250.
23. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid: thyroid deficiency in the Framingham study. Arch Intern Med. 1985; 145: 1386-1388.
24. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf). 1991; 34: 77-83.
25. Okamura K, Ueda K, Sone H, Ikenoue H, Hasuo Y, Sato K, et al. A sensitive thyroid stimulating hormone assay for screening of thyroid functional disorder in elderly Japanese. J Am Geriatr Soc. 1989; 37: 317-322.
26. Livingston EH, Hershman JM, Sawin CT, Yoshikawa TT. Prevalence of thyroid disease and abnormal thyroid tests in older hospitalized and ambulatory persons. J Am Geriatr Soc. 1987; 35: 109-114.
27. Krysiak R, Okopien B, Herman ZS. Subclinical thyroid disorders. Pol Merkur Lekarski. 2006; 21: 573-578.
28. Heydarian P, Azizi F. The frequency of thyroid autoantibodies is higher in the upper range of normal thyrotrophin values. Int J Endocrinol Metab. 2007; 1: 10-17.
29. Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K. Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab. 1994; 78: 393-397.
30. Galofré JC, García-Mayor RV, Fluiters E, Fernàndez-Calvet L, Rego A, Pàramo C, et al. Incidence of different forms of thyroid dysfunction and its degrees in an iodine-sufficient area. Thyroidology. 1994; 6: 49-54.
31. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002; 87: 489-499.
32. Mizukami Y, Michigishi T, Nonomura A, Hashimoto T, Tonami N, Matsubara F, et al. Iodine-induced hypothyroidism: a clinical and histological study of 28 patients. J Clin Endocrinol Metab. 1993; 76: 466-471.
33. DeGroot LJ. Multinodular goiter. In: DeGroot LJ, Larsen PR, Refetoff S, Stombury JB, eds. The Thyroid and its Diseases. 5th ed. New York: Wiley and Sons; 1984: 732-755.
34. Chow CC, Phillips DI, Lazarus JH, Parkes AB. Effect of low dose iodide supplementation on thyroid function in potentially susceptible subjects: are dietary iodide levels in Britain acceptable? Clin Endocrinol (Oxf). 1991; 34: 413-416.
35. Hoogendoorn EH, Hermus AR, de Vegt F, Ross HA, Verbeek AL, Kiemeney LA, et al. Thyroid function and prevalence of antithyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem. 2006; 52: 104-111.
36. O'Leary PC, Feddema PH, Michelangeli VP, Leedman PJ, Chew GT, Knuiman M, et al. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol (Oxf). 2006; 64: 97-104.
37. Shan ZY, Li YS, Wang ZY, Jin Y, Guan HX, Hu FN, et al. Effect of different iodine intake on the prevalence of hypothyroidism in 3 counties in China. Chin Med J (Engl). 2005; 118: 1918-1920.
38. Knudsen N, Jorgensen T, Rasmussen S, Christiansen E, Perrild H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin Endocrinol (Oxf). 1999; 51: 361-367.
39. Brussaard JH, Brants HA, Hulshof KF, Kistemaker C, Lowik MR. Iodine intake and urinary excretion among adults in the Netherlands. Eur J Clin Nutr. 1997; 51 (suppl 3): S59-S62.
40. Rasmussen LB, Ovesen L, Christiansen E. Day-to-day and within-day variation in urinary iodine excretion. Eur J Clin Nutr. 1999; 53: 401-407.
41. Als C, Helbling A, Peter K, Haldimann M, Zimmerli B, Gerber H. Urinary iodine concentration follows a circadian rhythm: a study with 3023 spot urine samples in adults and children. J Clin Endocrinol Metab. 2000; 85: 1367-1369.